DaVita Inc. (DVA)

NASDAQHealthcare

$105.05
+$1.1 (+1.1%)

January 21, 2026 at 19:16 UTC

Interactive Chart
DVA
1H
3H
6H
12H
1D
1W
1M
3M
6M
12M (YTD)
2Y
5Y
All
About DaVita Inc.

Name

DaVita Inc.

CEO

Javier J. Rodriguez

Industry

Healthcare

Year Founded

1994

Employees

76,000

DaVita Inc. provides kidney care focused on patients living with chronic kidney disease and end-stage renal disease. The company operates outpatient centers, supports home therapies, and coordinates with nephrologists, hospitals, and payers to deliver ongoing treatment and education. Clinical teams handle dialysis delivery, access monitoring, and patient training, while care management programs address nutrition, medication, and follow-up. Digital tools help track treatments and connect patients with support outside the clinic. DaVita works across the United States and select international markets, aligning service models with local regulations and provider networks. Positioned within the healthcare sector, the company’s role sits at the intersection of chronic care delivery, coordinated benefits, and community-based services.

Analyst Ratings
Consensus Recommendation
Analyst consensus: 1 Buy, 5 Hold, 15 Sell
Buy1
Hold5
Sell15
Fundamentals & Financials
Revenue (TTM)
$13.3B
Net Income (TTM)
$771.9M
EPS (TTM)
$9.94
ROA (TTM)
4.35%
Current Ratio
1.36
Dividend Yield
0.1%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Income Statement (Quarterly)
ItemQ3 2025
Revenue$3,420.2M
Cost of Sales$2,332.7M
Gross Profit$1,087.4M
Operating Income$505,767K
Net Income$150,332K
EPS$2.09
Technical Indicators

DaVita Inc.'s Technical Indicators Summary

DVA is exhibiting a clear bearish trend, supported by a strong ADX reading above 30 that confirms the downward momentum. The price is trading well below all key moving averages, including the critical 200-day level near 132, which reinforces the prevailing weakness. Momentum indicators like the MACD and CCI point to continued selling pressure, while the RSI is near oversold levels but only signaling a tentative buy. Despite stable volatility as reflected by the ATR, the declining on-balance volume suggests that selling activity remains dominant. Overall, DVA’s technical profile remains firmly negative with persistent bearish signals across trend, momentum, and volume measures.

Buy
1 signal
Neutral
5 signals
Sell
15 signals
Overall: Bearish71% Bearish signals
IndicatorValue
RSI (14)
29.32
Stochastic %K (14, 3, 3)
25.75
CCI (20)
-149.01
WPR (14)
-74.76
Momentum (10)
-9.77
MFI
32.34
MACD Level (12, 26)
-3.34
Bollinger Bands
$103.89 - $120.03
ATR (14)
$3.00 (2.86%)
ADX (14)
32.68
OBV
-27,103,700
Simple Moving Averages
$109.27 - $132.04(5 indicators)
Exponential Moving Averages
$108.37 - $131.84(5 indicators)
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.

Today's Snapshot

Price action at the open was nearly flat, with DVA easing -0.029% to 103.90 compared with yesterday’s 103.93. Early volumes are extremely muted, with DVA trading at just 0.09× its typical pace. DVA's slight decline and muted trading volume suggest limited stock-specific headlines and subdued market activity.

Price Change

from $103.93 close

+$2.65

Trading Volume

Below avg (961.6K)

89.4K

vs S&P 500 Today

Outperforming Market

+1.79%

52-Week Position

Near lows

7.1%

Updated: January 21, 2026 at 15:36 UTC

Quote Summary
OpenPrevious Close
$103.9$103.93
Day Range52 Week Range
$103.9 - $106.61$101 - $179.6
VolumeAvg. Volume
347.4K933.7K
Market CapP/E Ratio
$7.4B10.9